The integration of HPV-18 DNA in cervical carcinoma.

AIMS: Little information is available on the patterns of integration into the host chromosomal DNA of cervical carcinomas of human papillomavirus type 18 (HPV-18) DNA, which is associated with up to 20% of these carcinomas. Because integration of the viral genome may be extremely important in the pathogenesis of cervical carcinoma, the aim of this study was to investigate which regions of HPV-18 DNA are integrated into the cellular DNA of cervical carcinomas. METHODS: Southern analysis using four subgenomic probes covering the entire HPV-18 genome was used to map viral DNA integrated within cellular DNA. The polymerase chain reaction (PCR) was used to confirm the presence of specific regions of the viral genome. RESULTS: In all 11 carcinomas there was a single major HPV-18 DNA integrant, retaining approximately 4000 bp of HPV-18 DNA, indicating that approximately half of the virus genome had been lost upon integration. Southern analysis suggested strongly that the viral breakpoint was within the E1/E2 gene boundary, with concomitant loss of part or all of the E2 ORF (open reading frame), all of the E4, E5, and L2 ORFs and part of the L1 ORF. These data were supported by the PCR results, which confirmed that the region of integrated HPV-18 DNA from nucleotides 6558 to 162 was present in all the carcinoma samples studied. Assuming that no genomic rearrangements, deletions, or insertions had occurred, 4131 bp of integrated HPV-18 DNA could be accounted for in eight cervical carcinoma samples. The results of Southern analysis also suggested that integration of HPV-18 DNA may have occurred at a specific host chromosomal site. CONCLUSIONS: Broadly, the viral sequences retained upon HPV-18 integration resemble those found when HPV-16 is integrated. However, it appears that the HPV-18 E2 region is more consistently deleted.

[1]  K. Choo,et al.  Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: Frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions , 1996, Journal of medical virology.

[2]  K. Choo,et al.  Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: A rapid multiplex polymerase chain reaction approach , 1994, Journal of medical virology.

[3]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[4]  M. Yaniv,et al.  Control of HPV 18 DNA replication by cellular and viral transcription factors. , 1995, Nucleic acids research.

[5]  H. Hausen,et al.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. , 1984, The EMBO journal.

[6]  S. Schneider-Maunoury,et al.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression , 1991, Journal of virology.

[7]  M. Lehtinen,et al.  Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction , 1996, Cancer.

[8]  G. Mukherjee,et al.  Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. , 1995, The Journal of general virology.

[9]  P. Lazo,et al.  Deletion in Human Chromosome Region 12q13-15 by Integration of Human Papillomavirus DNA in a Cervical Carcinoma Cell Line (*) , 1995, The Journal of Biological Chemistry.

[10]  F. Stubenrauch,et al.  The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. , 1994, The EMBO journal.

[11]  D. K. Das,et al.  A high frequency of human papillomavirus DNA sequences in cervical carcinomas of indian women as revealed by southern blot hybridization and polymerase chain reaction , 1992, Journal of medical virology.

[12]  M. M. Pater,et al.  Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. , 1985, Virology.

[13]  Steven Wolinsky,et al.  The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .

[14]  M. Wagatsuma,et al.  Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences , 1990, Journal of virology.

[15]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[16]  H. Shirasawa,et al.  Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line. , 1989, The Journal of general virology.

[17]  H. Shirasawa,et al.  Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. , 1987, The Journal of general virology.

[18]  Y. Taketani,et al.  Type of human papillomavirus is related to clinical features of cervical carcinoma , 1996, Cancer.

[19]  P. Lazo.  Structure, DNaseI hypersensitivity and expression of integrated papilloma virus in the genome of HeLa cells. , 1987, European journal of biochemistry.

[20]  V. Gopalakrishna,et al.  Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. , 1992, The Journal of general virology.

[21]  S. Koi,et al.  Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. , 1989, Virology.

[22]  S. Wilczynski,et al.  Identification of HPV 16 early genes retained in cervical carcinomas. , 1988, Virology.

[23]  H. Bernard,et al.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID , 1994, Journal of virology.

[24]  R Reid,et al.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.

[25]  L. Villa,et al.  Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. , 1988, The Journal of general virology.

[26]  G. Mukherjee,et al.  The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. , 1997, The Journal of general virology.

[27]  G. Steger,et al.  Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein , 1997, Journal of virology.

[28]  H. Bernard,et al.  Transcription Factor Binding Sites in the Long Control Region of Genital HPVs , 1995 .

[29]  H. Shirasawa,et al.  Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas , 1988, Journal of virology.

[30]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Choo,et al.  Analysis of the unoccupied site of an integrated human papillomavirus 16 sequence in a cervical carcinoma. , 1990, Virology.

[32]  K. Choo,et al.  Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. , 1987, Virology.

[33]  H. Bernard,et al.  Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. , 1990, Nucleic acids research.

[34]  A. Easton,et al.  Detection of human papillomavirus in vulval carcinoma using semi-nested PCR and restriction enzyme typing: a rapid and sensitive technique , 1996, Clinical molecular pathology.

[35]  J. Trent,et al.  Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc , 1984, Nature.

[36]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[37]  Y. Taketani,et al.  Genomic Organization of Human Papillomavirus Type 18 in Cervical Cancer Specimens , 1996, Japanese journal of cancer research : Gann.

[38]  P. Fuchs,et al.  Human papillomavirus 16 dna in cervical cancers and in lymph nodes of cervical cancer patients: A diagnostic marker for early metastases? , 1989, International journal of cancer.

[39]  K. Choo,et al.  Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma , 1988, Journal of virology.

[40]  B. Gloss,et al.  The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element , 1990, Journal of virology.

[41]  A. García-Carrancá,et al.  Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes , 1994, International journal of cancer.

[42]  B. Gloss,et al.  During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. , 1992, Nucleic acids research.

[43]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.